Meanwhile EGCG alleviated FGF21 resistance and elevated FGFR/AMPK expression, which suggested an unrecognized mechanism of EGCG in ameliorating NAFLD. Here, FGF21 is linked to metabolic dysfunction-associated steatotic liver disease.